UMB Bank n.a. Decreases Stock Holdings in Danaher Co. (NYSE:DHR)

UMB Bank n.a. lessened its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,489 shares of the conglomerate's stock after selling 3,516 shares during the quarter. UMB Bank n.a.'s holdings in Danaher were worth $21,830,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund boosted its holdings in Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after purchasing an additional 2,202 shares during the period. FAS Wealth Partners Inc. increased its position in shares of Danaher by 20.6% in the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after purchasing an additional 1,639 shares during the last quarter. Generate Investment Management Ltd bought a new stake in Danaher during the fourth quarter valued at approximately $8,044,000. Channing Global Advisors LLC grew its stake in Danaher by 42.8% in the 4th quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock worth $1,301,000 after buying an additional 1,698 shares in the last quarter. Finally, Elevate Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter valued at $829,000. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Jefferies Financial Group decreased their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Wall Street Zen lowered shares of Danaher from a "buy" rating to a "hold" rating in a report on Monday. Royal Bank of Canada reissued an "outperform" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, April 23rd. HSBC cut their price target on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Finally, UBS Group decreased their price objective on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $263.24.

Danaher Stock Up 0.7%

Shares of Danaher stock traded up $1.42 during trading on Monday, hitting $197.44. The company's stock had a trading volume of 459,942 shares, compared to its average volume of 3,469,866. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a market capitalization of $141.30 billion, a PE ratio of 37.38, a P/E/G ratio of 2.66 and a beta of 0.77. The company has a fifty day simple moving average of $191.34 and a two-hundred day simple moving average of $212.03. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher's dividend payout ratio (DPR) is 24.85%.

Insider Buying and Selling

In other news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.